PARACELSUS HEALTHCARE CORP
8-K, 2000-09-20
GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Previous: ALLMERICA INVESTMENT TRUST, 497, 2000-09-20
Next: PARACELSUS HEALTHCARE CORP, 8-K, EX-99.1, 2000-09-20



==============================================================================


                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                          ---------------------------

                                   FORM 8-K

                                CURRENT REPORT

                    Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 15, 2000

                          ---------------------------


                        Commission file number 001-12055



                       PARACELSUS HEALTHCARE CORPORATION
            (Exact name of registrant as specified in its charter)





                CALIFORNIA                                   95-3565943
     (State or other jurisdiction of                       (IRS Employer
      incorporation or organization)                     Identification No.)


                 515 W. Greens Road, Suite 500, Houston, Texas
                   (Address of principal executive offices)



      77067                                            (281) 774-5100
    (Zip Code)                                (Registrant's telephone number,
                                                  including area code)



================================================================================








Items 1-2.  Not Applicable.

Item 3.  Bankruptcy or Receivership.

          On  September  15, 2000,  Paracelsus  Healthcare  Corporation  filed a
voluntary  petition under Chapter 11 of the United States  Bankruptcy  Code with
the United  States  Bankruptcy  Court for the  Southern  District  of Texas (the
"Court") (case no.  00-38590-H2-11).  The bankruptcy filing, which is limited to
the  parent  company  ("PHC"),  and  does  not  include  any of  PHC's  hospital
subsidiaries,   has  been   assigned  to   Bankruptcy   Judge  Karen  K.  Brown.
Simultaneously with the commencement of its bankruptcy case, PHC filed a Plan of
Reorganization (the "Plan") pursuant to which PHC proposes to effect its capital
restructuring.  PHC elected to seek Court  protection in order to facilitate the
restructuring   of  its  debt  while  continuing  to  maintain  normal  business
operations in PHC's hospital  subsidiaries.  PHC took this step with the support
of the holders of at least  two-thirds of the  principal  amount of PHC's $325.0
million 10% Senior  Subordinated  Notes (the "Notes").  PHC anticipates that the
current  directors and officers will continue in place subject to supervision by
the Court.

          PHC's hospital  subsidiaries have not filed for bankruptcy  protection
and are  expected to  continue  paying,  in the  ordinary  and normal  course of
business,  all wages,  benefits and other employee  obligations,  as well as all
outstanding and ongoing  accounts  payable to their  contractors and vendors.  A
recently completed $62 million credit facility, secured at the subsidiary level,
will not be directly  affected by PHC's filing and,  combined with cash on hand,
is expected to be sufficient to meet the working capital and capital expenditure
needs  of the  hospital  subsidiaries  during  the  restructuring  process.  The
hospitals remain open and will continue  providing health care services to their
patients.

         PHC's decision to restructure its debt was due to its highly  leveraged
capital   structure.   Despite  positive   earnings  before   interest,   taxes,
depreciation,  amortization  and unusual charges from hospital  operations,  the
high interest burden has severely impacted PHC's reinvestment opportunities.  In
an effort to  conserve  capital  and to preserve  the normal  operations  of the
hospital  subsidiaries,  PHC did not make its interest payments on the Notes due
February 15 and August 15, 2000.

         PHC has been in negotiations with the Note holders. Holders of at least
two-thirds of the principal amount of the Notes support the principal  financial
terms of the Plan and, subject to certain  conditions,  have indicated an intent
to vote in favor of the Plan. On the effective date of the Plan (the  "Effective
Date"),  all principal and interest  outstanding  on the Notes will be exchanged
for (i) the  reorganized  PHC 11.5% Senior Notes (due on August 15, 2005) in the
aggregate  principal amount of $130.0 million (the "New Notes"),  and (ii) 95.0%
of the reorganized PHC common stock, subject to dilution through the exercise of
the Series A Warrants and Series B Warrants (as referred to below).  Interest on
the New Notes shall accrue commencing on August 15, 2000. The Plan also provides
for the holders of PHC's  common  stock as of the Record Date (as defined in the
Plan) to (i) receive 5.0% of the  reorganized  PHC's common stock,  (ii) receive
warrants (the "Series A Warrants") to purchase prior to the fifth anniversary of
the  Effective  Date an  additional  9.64% of the  reorganized  PHC common stock
(exercisable at $320.0 million  enterprise  value of the  reorganized  PHC), and
(iii) receive  warrants (the "Series B Warrants") to purchase prior to the first
anniversary  of the Effective  Date an additional  2.0% of the  reorganized  PHC
common stock  (exercisable at $100.0 million value of the reorganized PHC common
stock).  The Plan would make its  effectiveness  subject to certain  conditions,
such as limiting  the amount of allowed and  undisputed  unsecured  claims other
than  the  Notes  to  $15.0  million.  The  Plan,  as well as  PHC's  Disclosure
Statement,  are on file with the Court and are  available for review and copying
during the Court's normal business hours.

          A copy of the press  release  issued by the  Company is included as an
exhibit to this filing and is incorporated herein by reference.

         Certain statements  contained herein are  "forward-looking  statements"
made pursuant to the safe harbor provisions of the Private Securities Litigation
Reform  Act of 1995.  Forward-looking  statements  involve a number of risks and
uncertainties.  All statements regarding the Company's expected future financial
position,  results  of  operations,  cash  flows,  liquidity,  financing  plans,
business   strategy,   budgets,   projected  costs  and  capital   expenditures,
competitive position,  growth opportunities,  plans and objectives of management
for  future  operations  and  words  such as  "anticipate,"  "believe,"  "plan,"
"estimate,"   "expect,"  "intend,"  "may"  and  other  similar  expressions  are
forward-looking  statements.  Such  forward-looking  statements  are  inherently
uncertain,  and  stockholders  must  recognize  that  actual  results may differ
materially from the Company's  expectations as a result of a variety of factors,
including, without limitation, those discussed below.

         Factors which may cause the Company's  actual results in future periods
to differ  materially from forecast results include,  but are not limited to: i)
Competition  and general  economic,  demographic and business  conditions,  both
nationally  and in the  regions  in which the  Company  operates;  ii)  Existing
government  regulations  and changes in  legislative  proposals  for  healthcare
reform,  including changes in Medicare and Medicaid  reimbursement  levels; iii)
The ability to enter into  managed  care  provider  arrangements  on  acceptable
terms;  iv) Liabilities and other claims  asserted  against the Company;  v) The
loss of any  significant  customer,  including  but not limited to managed  care
contracts; vi) The ability to attract and retain qualified personnel,  including
physicians  and  vii)  Uncertainties  associated  with  the  outcomes  of  PHC's
bankruptcy proceedings.

          The Company is generally  not required to, and does not  undertake to,
update or revise its forward-looking statements.

Items 4-6.  Not Applicable.

Item 7.  Financial Statements and Exhibits.

     (a)  Financial statements of businesses acquired.

          Not applicable.

     (b)  Pro forma financial information.

          Not applicable.

     (c)  Exhibits.

     Exhibit 99.1 Press Release dated September 15, 2000.

Items 8-9.  Not Applicable.


























                                    SIGNATURE

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                       Paracelsus Healthcare Corporation
                                                 (Registrant)


Dated: September 19, 2000               By: /S/    LAWRENCE A. HUMPHREY
                                       ----------------------------------
                                             Lawrence A. Humphrey
                                           Executive Vice President,
                                          & Chief Financial Officer


















































© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission